Lv1
86 积分 2025-03-13 加入
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells
19小时前
已完结
Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages
1天前
已完结
Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α
3天前
已完结
Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice
4天前
已完结
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
9天前
已完结
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
1个月前
已完结
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
2个月前
已完结
Genome-wide CRISPR screen identifies TAF1C as an epigenetic determinant of lipid deposition via ACSL4-dependent ferroptosis in MASLD
3个月前
已完结
ZNF296 Drives Immune Evasion in Epithelial Cancers by Repressing Immune Stimulatory Genes
4个月前
已完结
Targeting TFAP2β condensation suppresses the development of esophageal squamous cell carcinoma
4个月前
已完结
皖公网安备34019202002308
